chr16-10430802-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001393719.1(ATF7IP2):c.182C>T(p.Thr61Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000039 ( 0 hom., cov: 0)
Exomes 𝑓: 0.000054 ( 0 hom. )
Consequence
ATF7IP2
NM_001393719.1 missense
NM_001393719.1 missense
Scores
1
18
Clinical Significance
Conservation
PhyloP100: -2.15
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.055778682).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATF7IP2 | NM_001393719.1 | c.182C>T | p.Thr61Met | missense_variant | 5/14 | ENST00000562102.6 | NP_001380648.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATF7IP2 | ENST00000562102.6 | c.182C>T | p.Thr61Met | missense_variant | 5/14 | 4 | NM_001393719.1 | ENSP00000457731 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000393 AC: 1AN: 25468Hom.: 0 Cov.: 0
GnomAD3 genomes
AF:
AC:
1
AN:
25468
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250694Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135530
GnomAD3 exomes
AF:
AC:
1
AN:
250694
Hom.:
AF XY:
AC XY:
1
AN XY:
135530
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000539 AC: 12AN: 222588Hom.: 0 Cov.: 0 AF XY: 0.0000451 AC XY: 5AN XY: 110752
GnomAD4 exome
AF:
AC:
12
AN:
222588
Hom.:
Cov.:
0
AF XY:
AC XY:
5
AN XY:
110752
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000393 AC: 1AN: 25468Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 12248
GnomAD4 genome
AF:
AC:
1
AN:
25468
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
12248
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ExAC
AF:
AC:
1
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2021 | The c.182C>T (p.T61M) alteration is located in exon 2 (coding exon 1) of the ATF7IP2 gene. This alteration results from a C to T substitution at nucleotide position 182, causing the threonine (T) at amino acid position 61 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;.;.;.;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
.;.;T;T;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N;.;.;N;N
MutationTaster
Benign
N;N;N;N;N
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N;N;N;N
REVEL
Benign
Sift
Uncertain
D;D;T;T;D;D
Sift4G
Benign
T;D;T;T;D;T
Polyphen
P;B;.;.;B;P
Vest4
MutPred
Gain of catalytic residue at V57 (P = 0.0466);Gain of catalytic residue at V57 (P = 0.0466);Gain of catalytic residue at V57 (P = 0.0466);Gain of catalytic residue at V57 (P = 0.0466);Gain of catalytic residue at V57 (P = 0.0466);Gain of catalytic residue at V57 (P = 0.0466);
MVP
MPC
ClinPred
T
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at